Trodelvy User Reviews & Ratings
Trodelvy has an average rating of 8.0 out of 10 from a total of 3 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Breast Cancer | 3 reviews for Breast Cancer | 80 medications |
- Jan...
- Taken for 1 to 6 months
- January 19, 2024
For Breast Cancer "I occasionally have slurred speech and difficulty swallowing. It's kind of intermittent. No other side effect except complete alopecia"
- Sta...
- Taken for 1 to 6 months
- April 24, 2024
For Breast Cancer "Horrible paralyzing bone pain. Horrible constipation or diarrhea. Horrible experience. Also, face numbness."
Frequently asked questions
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Trodelvy (sacituzumab govitecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
For Breast Cancer "Other than neutropenia and alopecia, my side effects are minimal. I'm in the middle of my treatment plan, still hopeful that this will give me a sustained remission."